142 related articles for article (PubMed ID: 32387137)
1. In vivo evaluation of effects of histamine H
Kitanaka J; Kitanaka N; Hall FS; Amatsu Y; Hashimoto K; Hisatomi E; Kitao E; Mimura M; Nakamura M; Ozawa R; Sato M; Tagami K; Uhl GR; Takemura M
Brain Res; 2020 Aug; 1740():146873. PubMed ID: 32387137
[TBL] [Abstract][Full Text] [Related]
2. Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice.
Kitanaka N; Hall FS; Kobori S; Kushihara S; Oyama H; Sasaoka Y; Takechi M; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
Pharmacol Biochem Behav; 2021 Oct; 209():173257. PubMed ID: 34418452
[TBL] [Abstract][Full Text] [Related]
3. Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.
Kitanaka J; Kitanaka N; Tatsuta T; Morita Y; Takemura M
Neuroscience; 2007 Jul; 147(3):765-77. PubMed ID: 17570600
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with l-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Miyoshi A; Koumoto A; Tanaka K; Nishiyama N; Morita Y; Takemura M
Pharmacol Biochem Behav; 2010 Jan; 94(3):464-70. PubMed ID: 19895842
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
[TBL] [Abstract][Full Text] [Related]
6. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats.
Ito C; Onodera K; Watanabe T; Sato M
Psychopharmacology (Berl); 1997 Apr; 130(4):362-7. PubMed ID: 9160852
[TBL] [Abstract][Full Text] [Related]
7. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
[TBL] [Abstract][Full Text] [Related]
8. Are Histamine H
Kitanaka N; Hall FS; Tanaka KI; Tomita K; Igarashi K; Nishiyama N; Sato T; Uhl GR; Kitanaka J
Curr Drug Res Rev; 2022; 14(3):162-170. PubMed ID: 35431009
[TBL] [Abstract][Full Text] [Related]
9. Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tatsuta T; Morita Y; Tanaka K; Nishiyama N; Takemura M
Neurochem Res; 2011 Oct; 36(10):1824-33. PubMed ID: 21573995
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
Kitanaka N; Kitanaka J; Takemura M
Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686
[TBL] [Abstract][Full Text] [Related]
11. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
Molenhuis RT; Hutten L; Kas MJH
Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
[TBL] [Abstract][Full Text] [Related]
12. The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Fukushima Y; Sawai T; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Tatsuta T; Morita Y; Takemura M
Brain Res; 2013 Jul; 1522():88-98. PubMed ID: 23727404
[TBL] [Abstract][Full Text] [Related]
13. Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.
Jiang L; Zhu R; Bu Q; Li Y; Shao X; Gu H; Kong J; Luo L; Long H; Guo W; Tian J; Zhao Y; Cen X
Neurotherapeutics; 2018 Apr; 15(2):500-510. PubMed ID: 29464572
[TBL] [Abstract][Full Text] [Related]
14. Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice.
Takino N; Sakurai E; Kuramasu A; Okamura N; Yanai K
Int Rev Neurobiol; 2009; 85():109-16. PubMed ID: 19607964
[TBL] [Abstract][Full Text] [Related]
15. Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
Kitanaka N; Kitanaka J; Hall FS; Uhl GR; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Takemura M
Behav Pharmacol; 2014 Apr; 25(2):158-65. PubMed ID: 24557322
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system.
Mori T; Narita M; Onodera K; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Jun; 22(3):73-8. PubMed ID: 12166087
[TBL] [Abstract][Full Text] [Related]
17. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
18. The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.
Khan N; Saad A; Nurulain SM; Darras FH; Decker M; Sadek B
Behav Brain Res; 2016 Jan; 297():155-64. PubMed ID: 26467607
[TBL] [Abstract][Full Text] [Related]
19. H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice.
Dudek M; Kuder K; Kołaczkowski M; Olczyk A; Żmudzka E; Rak A; Bednarski M; Pytka K; Sapa J; Kieć-Kononowicz K
Metab Brain Dis; 2016 Oct; 31(5):1023-9. PubMed ID: 27216278
[TBL] [Abstract][Full Text] [Related]
20. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Yun J
Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
